We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

220 hedge funds and large institutions have $481M invested in Editas Medicine in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 76 increasing their positions, 62 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $3.5M

23% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 62

2.27% less ownership

Funds ownership: 77.04% → 74.77% (-2.3%)

7% less capital invested

Capital invested by funds: $517M → $481M (-$35.8M)

7% less funds holding

Funds holding: 237 → 220 (-17)

38% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 40

Holders
220
Holders Change
-17
Holders Change %
-7.17%
% of All Funds
3.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
76
Reduced
62
Closed
40
Calls
$6.11M
Puts
$3.5M
Net Calls
+$2.61M
Net Calls Change
-$919K

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$31.3M
2
BlackRock
BlackRock
New York
+$4.84M
3
WP
Woodline Partners
California
+$4.38M
4
Squarepoint
Squarepoint
New York
+$4.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.18M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$24.7M
2
GCM
Ghisallo Capital Management
Massachusetts
-$8.02M
3
State Street
State Street
Massachusetts
-$7.47M
4
Man Group
Man Group
United Kingdom
-$6.35M
5
Marshall Wace
Marshall Wace
United Kingdom
-$5.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2.85M +$260K +30,306 +9%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.7M +$670K +78,127 +29%
Bank of America
28
Bank of America
North Carolina
$2.56M -$854K -99,605 -23%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.45M +$335K +39,076 +14%
Barclays
30
Barclays
United Kingdom
$2.15M -$208K -24,270 -8%
RJA
31
Raymond James & Associates
Florida
$2.14M +$129K +14,994 +6%
SOMRS
32
State of Michigan Retirement System
Michigan
$2.14M – – –
Citigroup
33
Citigroup
New York
$1.66M +$219K +25,532 +14%
Wells Fargo
34
Wells Fargo
California
$1.64M -$49.1K -5,722 -3%
TCM
35
Tang Capital Management
California
$1.56M – – –
TI
36
Trexquant Investment
Connecticut
$1.46M +$924K +107,776 +135%
Swiss National Bank
37
Swiss National Bank
Switzerland
$1.4M +$16.3K +1,900 +1%
PP
38
PDT Partners
New York
$1.22M +$638K +74,374 +91%
Stifel Financial
39
Stifel Financial
Missouri
$1.19M +$32K +3,730 +3%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$1.03M +$123K +14,360 +12%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
41
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$944K +$1.04M +121,000 New
SFI
42
Susquehanna Fundamental Investments
Pennsylvania
$930K – – –
ECM
43
ExodusPoint Capital Management
New York
$895K -$2.43M -283,301 -71%
UBS Group
44
UBS Group
Switzerland
$849K -$659K -76,799 -41%
Axa
45
Axa
France
$741K -$90K -10,500 -10%
UBS AM
46
UBS AM
Illinois
$725K +$167K +19,449 +26%
Jennison Associates
47
Jennison Associates
New York
$724K -$214K -24,981 -21%
CAM
48
Congress Asset Management
Massachusetts
$704K +$1.03K +120 +0.1%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$704K -$39.7K -4,634 -5%
Fidelity Investments
50
Fidelity Investments
Massachusetts
$666K +$51.9K +6,048 +8%
1
2
3 4 5

EDIT Hedge Fund Activity: Q3 2023 in Review

220 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2023, worth a combined $481M — down 6.9% from $517M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of EDIT and 25 opened new positions — a net loss of 15 holders — while 62 trimmed existing stakes and 76 added.

The largest buyer was Deep Track Capital, adding an estimated $31.3M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $24.7M sold.

  • 220 institutional investors held Editas Medicine (EDIT) as of Q3 2023, down from 237 in Q2 2023.
  • Funds reported $481M of Editas Medicine stock for Q3 2023, down 6.9% quarter-over-quarter.
  • 25 funds opened new Editas Medicine positions in Q3 2023 and 40 closed out, a net change of -15 holders.
  • The largest Editas Medicine buyer in Q3 2023 was Deep Track Capital, an estimated $31.3M added.
  • The largest Editas Medicine seller in Q3 2023 was Avidity Partners Management, an estimated $24.7M sold.

Based on aggregated 13F filings for Q3 2023.